These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35489983)

  • 1. Severe Acute Respiratory Syndrome Coronavirus 2 Cross-Reactive B and T Cell Responses in Kidney Transplant Patients.
    Paniskaki K; Anft M; Thieme CJ; Skrzypczyk S; Konik MJ; Dolff S; Westhoff TH; Nienen M; Stittrich A; Stervbo U; Witzke O; Heine G; Roch T; Babel N
    Transplant Proc; 2022; 54(6):1455-1464. PubMed ID: 35489983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Magnitude and Functionality of SARS-CoV-2 Reactive Cellular and Humoral Immunity in Transplant Population Is Similar to the General Population Despite Immunosuppression.
    Thieme CJ; Anft M; Paniskaki K; Blazquez-Navarro A; Doevelaar A; Seibert FS; Hoelzer B; Justine Konik M; Meister TL; Pfaender S; Steinmann E; Moritz Berger M; Brenner T; Kölsch U; Dolff S; Roch T; Witzke O; Schenker P; Viebahn R; Stervbo U; Westhoff TH; Babel N
    Transplantation; 2021 Oct; 105(10):2156-2164. PubMed ID: 33988334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients.
    Steiner S; Sotzny F; Bauer S; Na IK; Schmueck-Henneresse M; Corman VM; Schwarz T; Drosten C; Wendering DJ; Behrends U; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2020; 11():607918. PubMed ID: 33424856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses of lung transplant recipients against SARS-CoV-2 and common respiratory coronaviruses: Evidence for pre-existing cross-reactive immunity.
    Bansal S; Fleming T; Canez J; Maine GN; Bharat A; Walia R; Tokman S; Smith MA; Tiffany B; Bremner RM; Mohanakumar T
    Transpl Immunol; 2023 Dec; 81():101940. PubMed ID: 37866672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patients.
    Anft M; Blazquez-Navarro A; Stervbo U; Skrzypczyk S; Witzke O; Wirth R; Choi M; Hugo C; Reinke P; Meister TL; Steinmann E; Pfaender S; Schenker P; Viebahn R; Westhoff TH; Babel N
    J Nephrol; 2021 Aug; 34(4):1025-1037. PubMed ID: 34228322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.
    Hartzell S; Bin S; Benedetti C; Haverly M; Gallon L; Zaza G; Riella LV; Menon MC; Florman S; Rahman AH; Leech JM; Heeger PS; Cravedi P
    Am J Transplant; 2020 Nov; 20(11):3149-3161. PubMed ID: 32786152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.
    Braun J; Loyal L; Frentsch M; Wendisch D; Georg P; Kurth F; Hippenstiel S; Dingeldey M; Kruse B; Fauchere F; Baysal E; Mangold M; Henze L; Lauster R; Mall MA; Beyer K; Röhmel J; Voigt S; Schmitz J; Miltenyi S; Demuth I; Müller MA; Hocke A; Witzenrath M; Suttorp N; Kern F; Reimer U; Wenschuh H; Drosten C; Corman VM; Giesecke-Thiel C; Sander LE; Thiel A
    Nature; 2020 Nov; 587(7833):270-274. PubMed ID: 32726801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals.
    Zhang J; Wu Q; Liu Z; Wang Q; Wu J; Hu Y; Bai T; Xie T; Huang M; Wu T; Peng D; Huang W; Jin K; Niu L; Guo W; Luo D; Lei D; Wu Z; Li G; Huang R; Lin Y; Xie X; He S; Deng Y; Liu J; Li W; Lu Z; Chen H; Zeng T; Luo Q; Li YP; Wang Y; Liu W; Qu X
    Nat Microbiol; 2021 Jan; 6(1):51-58. PubMed ID: 33199863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term, CD4
    Wirsching S; Harder L; Heymanns M; Gröndahl B; Hilbert K; Kowalzik F; Meyer C; Gehring S
    Front Immunol; 2022; 13():800070. PubMed ID: 35514974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses.
    Wratil PR; Schmacke NA; Karakoc B; Dulovic A; Junker D; Becker M; Rothbauer U; Osterman A; Spaeth PM; Ruhle A; Gapp M; Schneider S; Muenchhoff M; Hellmuth JC; Scherer C; Mayerle J; Reincke M; Behr J; Kääb S; Zwissler B; von Bergwelt-Baildon M; Eberle J; Kaderali L; Schneiderhan-Marra N; Hornung V; Keppler OT
    Cell Rep; 2021 Dec; 37(13):110169. PubMed ID: 34932974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
    Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
    J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19.
    Kirchner T; Heinrich S; Bonifacius A; Engel B; Ruhl L; Pink I; Thomas N; Martens J; Hoeper MM; Blasczyk R; Wedemeyer H; Jaeckel E; Li Y; Falk CS; Eiz-Vesper B; Taubert R
    PLoS One; 2022; 17(11):e0276929. PubMed ID: 36322587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients.
    Citores MJ; Caballero-Marcos A; Cuervas-Mons V; Alonso-Fernández R; Graus-Morales J; Arias-Milla A; Valerio M; Muñoz P; Salcedo M
    J Microbiol Immunol Infect; 2023 Jun; 56(3):526-536. PubMed ID: 36964052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient.
    Babel N; Anft M; Blazquez-Navarro A; Doevelaar AAN; Seibert FS; Bauer F; Rohn BJ; Hoelzer B; Thieme CJ; Roch T; Meister TL; Pfaender S; Steinmann E; Dittmer U; Schenker P; Amann K; Viebahn R; Stervbo U; Westhoff TH
    Am J Transplant; 2020 Nov; 20(11):3210-3215. PubMed ID: 32777178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
    Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2021; 12():687449. PubMed ID: 34322120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney transplant rejection rate in screened patients for anti-SARS-CoV-2 antibodies, during COVID-19 pandemic in Northern Italy.
    Asti AL; Lilleri D; Gregorini M; Zelini P; Pattonieri EF; Sepe V; Libetta C; Islami T; Baldanti F; Rampino T
    New Microbiol; 2021 Jul; 44(3):184-186. PubMed ID: 34783351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Henss L; Scholz T; von Rhein C; Wieters I; Borgans F; Eberhardt FJ; Zacharowski K; Ciesek S; Rohde G; Vehreschild M; Stephan C; Wolf T; Hofmann-Winkler H; Scheiblauer H; Schnierle BS
    J Infect Dis; 2021 Jan; 223(1):56-61. PubMed ID: 33128369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.